Dx & Vx Co., Ltd. (KOSDAQ:180400)
South Korea · Delayed Price · Currency is KRW 2,500.00
+115.00 (4.82%)
At close: Jul 10, 2026
Dx & Vx Market Cap
Dx & Vx has a market cap or net worth of 246.07 billion as of July 10, 2026. Its market cap has increased by 142.11% in one year.
Market Cap
246.07B
Enterprise Value
198.93B
Revenue
28.48B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,500.00
Market Cap Chart
Since November 20, 2015, Dx & Vx's market cap has increased from 75.32B to 246.07B, an increase of 226.72%. That is a compound annual growth rate of 11.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 246.07B | 59.22% |
| Dec 30, 2025 | 154.55B | 68.91% |
| Dec 30, 2024 | 91.50B | -48.77% |
| Dec 28, 2023 | 178.59B | 52.96% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3billion | 187.75B |
| GENINUS | 87.45B |
| Cytogen | 71.86B |
| Inventera | 65.60B |
| GC Medical Science | 61.20B |
| Protia | 53.06B |
| HLB Panagene | 50.54B |
| Seoulin Bioscience | 41.09B |